The company had posted a net profit of Rs 244 crore for the corresponding period of the previous fiscal, Torrent Pharmaceuticals said in a filing to the BSE.
The firm's consolidated net income from operations stood at Rs 1,154 crore for the quarter under consideration as against Rs 1,225 crore for the same period a year ago.
The consolidated net profit of the company, however, rose to Rs 751 crore for the financial year ended March 31, 2015 from Rs 664 crore in the year-ago period.
Meanwhile, in a separate filing, Torrent Pharmaceuticals said its Board of Directors has recommended a final dividend of Rs 6.25 per equity share of Rs 5 each, fully paid up further to the interim dividend of Rs 5 per equity share paid during the last quarter.
Torrent Pharmaceuticals shares closed 0.11 per cent up at Rs 1,256.55 per scrip on the BSE.